Neogenomics (NEO) Interest Expenses (2011 - 2026)

Neogenomics (NEO) has reported Interest Expenses for 13 consecutive years, with $598000.0 the latest figure, recorded in Q1 2026.

• Interest Expenses for Q1 2026 came in at $598000.0, down 63.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 million (down 58.27% YoY), and the FY2025 annual result was $3.8 million, down 43.28% from the prior year.
• Interest Expenses was $598000.0 for Q1 2026 at Neogenomics, roughly flat from $599000.0 in the prior quarter.
• Over five years, Interest Expenses peaked at $5.2 million in Q4 2022 and troughed at $139000.0 in Q3 2022.
• Average Interest Expenses over 5 years is $1.5 million, with a median of $1.6 million recorded in 2024.
• Year-over-year, Interest Expenses slumped 89.27% in 2022 and soared 1112.23% in 2023.
• Over 5 years, Interest Expenses stood at $5.2 million in 2022, then tumbled by 67.77% to $1.7 million in 2023, then dropped by 3.39% to $1.6 million in 2024, then slumped by 63.12% to $599000.0 in 2025, then retreated by 0.17% to $598000.0 in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $598000.0 in Q1 2026, $599000.0 in Q4 2025, and $603000.0 in Q3 2025.